Gene Logic, Inc. GLGC

Gene Logic, Inc. 708 Quince Orchard Road Gaithersburg, MD 20878
Locations Update This Record Cases by Outcome Cases by Type	SEC CIK 1043914

Add a document

Description
Summary
Document Type	Academic Paper Corporate Document - Internal Corporate Document - Public Court Document Equity Research Government Document - Federal Government Document - State Government Document - Local FBI File Public Records Request Response - FOIA Public Records Request Response - State Non-Profit Report Police Report White Paper
Document Date
Document Source
Source URL
File
	If you would like to be credited for contributing this document, make sure to sign in or sign up first. Once uploaded, your document may not be immediately visible to the public as we review each document for legal issues. Thanks for your patience!

Go Pro to view an analysis and graphs of case roles, types and more.

Filter By From To

	Date Filed	Venue	Case Number	Title	Party Type
	5/5/2006	USPTO Trademark Trial and Appeal Board	91170762-OPP	Gene Logic Inc. v. Ascenta Therapeutics, Inc.	Plaintiff
	12/8/2005	USPTO Trademark Trial and Appeal Board	76628224-EXT	Gene Logic Inc. v. Ascenta Therapeutics, Inc.	Potential Opposer
	10/27/2005	USPTO Trademark Trial and Appeal Board	91167175-OPP	Gene Logic, Inc v. Genologics Life Sciences Software Inc.	Plaintiff
	5/4/2005	USPTO Trademark Trial and Appeal Board	78194810-EXT	Gene Logic, Inc v. Genologics Life Sciences Software Inc.	Potential Opposer
	11/17/2004	USPTO Trademark Trial and Appeal Board	76442091-EXA	In re Gene Logic, Inc., Serial No. 76442091	Plaintiff
	7/29/2004	USPTO Trademark Trial and Appeal Board	76503030-EXT	Pei-genesis, Inc. v. Gene Logic, Inc.	Defendant
	12/23/2003	USPTO Trademark Trial and Appeal Board	76505420-EXT	Bayer Healthcare Llc v. Gene Logic, Inc.	Defendant
	2/14/2003	USPTO Trademark Trial and Appeal Board	75837517-EXT	Gene Logic, Inc. v. Protein Sciences Corporation	Potential Opposer
	12/30/2002	USPTO Trademark Trial and Appeal Board	75483780-EXT	Gene Logic, Inc v. Protein Sciences Corporation	Potential Opposer
	8/17/2000	California Northern District Court	3:00-cv-04627	Incyte Genomics, Inc v. Gene Logic, Inc.	Defendant
	8/17/2000	California Northern District Court	3:00-cv-04627	Incyte Genomics, Inc v. Gene Logic, Inc.	Counter-claimant
	8/17/2000	California Northern District Court	3:00-cv-04627	Incyte Genomics, Inc v. Gene Logic, Inc.	Counter-claimant
	12/6/1999	California Northern District Court	3:99-cv-05180	Incyte Pharmaceutica v. Gene Logic, Inc.	Defendant

13 Rows Total

Inside Counsel (0)

Go Pro to view corporate inside counsel.

Outside Counsel (30)

	Last Name	First Name	Middle Name	Firm	Location
	&	Morgan	Lewis	Attn Tmsu
	Albrecht	Ralph	P.	Venable LLP	Vienna, VA
	Alder	Reid	G.	Morgan, Lewis & Bockius, LLP
	Bergstrom	Robert	W.	Weiss Jensen Ellis & Howard	Seattle, WA
	Eisner	Charles	I.	Boornazian Jensen & Garthe	Oakland, CA
	G.	Mr.	Ried	Morgan, Lewis & Bockius, LLP
	GROUP	PATENT		Cooley LLP	Washington, DC
	Halluin	Albert	P.	Howrey LLP	Menlo Park, CA
	Hayman	Mark	L.		Washington, DC
	Hewitt	Jason	L.	Morgan, Lewis & Bockius, LLP
	Leung	Jacqueline	Jordan	Boornazian, Jensen,& Garthe	Oakland, CA
	Mackuire	Peter	G.	Foley & Lardner, LLP
	Mcleod	Bonnie	Weiss	Morgan, Lewis & Bockius, LLP	Washington, DC
	Meath	Gregory	T.	Morgan, Lewis & Bockius, LLP	Stockton, CA
	Millstein	Larry		MILLSTEIN & TAYLOR, PC
	Musick	Eleanor	M.	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Musick	Eleanor	M.		San Diego, CA
	Musicks	Eleanor	M.	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Placeholder	TTAB	Attorney	Morgan, Lewis & Bockius, LLP
	Placeholder	TTAB	Attorney	Morgan, Lewis & Bockius, LLP
	Pratt	John	S.	Kilpatrick Townsend & Stockton, LLP	Atlanta, GA
	Sandercock	Colin		Foley & Lardner, LLP
	Skilton	John	S.	Heller Ehrman LLP	Wi,
	SMYTH	ROBERT		Morgan, Lewis & Bockius, LLP
	Tuscan	Michael	S.	Morgan, Lewis & Bockius, LLP	Washington, DC
	Tuscan	Michael	S.	Morgan, Lewis & Bockius, LLP
	Tuscan	Michael	S.		Washington, DC
	Washington	Joseph	E.	Morgan, Lewis & Bockius, LLP	Washington, DC
	Weatherspoon	John		Morgan, Lewis & Bockius, LLP	Washington, DC
	Wilson	Jon	Martin	Foley & Lardner, LLP	Los Angeles, CA

30 Rows Total

Filter By Form All Records 10-K 10-K/A 10-K405 10-Q 15-12G 25-NSE 3 4 4/A 424A 424B3 424B4 425 5 8-A12G 8-K 8-K/A ARS CT ORDER DEF 14A DEFA14A EFFECT POS AM PRE 14A REGDEX S-1 S-1/A S-3 S-3/A S-3MEF S-4 S-4/A S-8 S-8 POS SC 13D SC 13D/A SC 13G SC 13G/A SC TO-I SC TO-I/A From To

	Date	Entity	Form Number	Description
	2/11/2011		SC 13G/A
	11/5/2010	Gibson Terry	3	Initial statement of beneficial ownership of securities
	11/1/2010		SC 13D
	11/1/2010	Howard Jack L	3	Initial statement of beneficial ownership of securities
	11/1/2010	Kong Kenneth	3	Initial statement of beneficial ownership of securities
	10/29/2010	Lichtenstein Warren G	4	Statement of changes in beneficial ownership of securities
	10/29/2010	Lichtenstein Warren G	3	Initial statement of beneficial ownership of securities
	9/24/2010		15-12G
	9/23/2010		CT ORDER
	8/11/2010		10-Q
	7/22/2010		8-K	Current report pursuant to Section 13 or 15(d)
	5/11/2010		10-Q
	4/29/2010		10-K/A
	4/19/2010		8-K	Current report pursuant to Section 13 or 15(d)
	4/5/2010		25-NSE
	3/31/2010		10-K	Annual report pursuant to Section 13 or 15(d)
	3/22/2010		8-K	Current report pursuant to Section 13 or 15(d)
	2/12/2010		SC 13G/A
	2/12/2010		8-K	Current report pursuant to Section 13 or 15(d)
	2/8/2010		SC 13G/A
	2/3/2010		8-K	Current report pursuant to Section 13 or 15(d)
	1/20/2010	Donahue, Stephen R.	4	Statement of changes in beneficial ownership of securities
	1/20/2010	Palleiko Benjamin L	4	Statement of changes in beneficial ownership of securities
	12/2/2009	Gabrielson, Mark J.	4	Statement of changes in beneficial ownership of securities
	12/1/2009	Fordyce James W	4	Statement of changes in beneficial ownership of securities
	11/25/2009	Fordyce James W	4	Statement of changes in beneficial ownership of securities
	11/23/2009	Gabrielson, Mark J.	4	Statement of changes in beneficial ownership of securities
	11/23/2009	Fordyce James W	4	Statement of changes in beneficial ownership of securities
	11/20/2009	Fordyce James W	4	Statement of changes in beneficial ownership of securities
	11/16/2009		S-8
	11/16/2009		S-8 POS
	11/13/2009		8-K	Current report pursuant to Section 13 or 15(d)
	11/13/2009		10-Q
	10/22/2009	Thompson J Stark Phd	4	Statement of changes in beneficial ownership of securities
	10/22/2009	Fordyce James W	4	Statement of changes in beneficial ownership of securities
	10/22/2009	Urdal, David	4	Statement of changes in beneficial ownership of securities
	10/22/2009	Gorry G Anthony Phd	4	Statement of changes in beneficial ownership of securities
	10/21/2009		8-K	Current report pursuant to Section 13 or 15(d)
	9/18/2009		8-K	Current report pursuant to Section 13 or 15(d)
	9/10/2009		ARS
	9/10/2009		8-K	Current report pursuant to Section 13 or 15(d)
	9/10/2009		425	Prospectuses and communications, business combinations
	9/9/2009		8-K	Current report pursuant to Section 13 or 15(d)
	9/9/2009		425	Prospectuses and communications, business combinations
	9/3/2009		EFFECT
	9/2/2009		S-4/A
	8/28/2009	Gabrielson, Mark J.	4	Statement of changes in beneficial ownership of securities
	8/20/2009		8-K	Current report pursuant to Section 13 or 15(d)
	8/20/2009		425	Prospectuses and communications, business combinations
	8/19/2009		8-K	Current report pursuant to Section 13 or 15(d)

439 Rows Total	Page 1 of 9 | Go To

	Date Recorded	Party	Role	Document Type	Document No.	Invention Title
	6/11/2010	Gene Logic Acquisition Corporation	Assignor	Application Publication	12466663 20090325238	Method of Analyzing a BRCA2 Gene in a Human Subject Method of Analyzing a BRCA2 Gene in a Human Subject
	6/11/2010	Ore Pharmaceuticals, Inc.	Assignee	Application Publication	12466663 20090325238	Method of Analyzing a BRCA2 Gene in a Human Subject Method of Analyzing a BRCA2 Gene in a Human Subject
	5/24/2010	Gene Logic Acquisition Corporation	Assignor	Application Publication	12402298 20090269814	Method of Analyzing a BRCA2 Gene in a Human Subject Method of Analyzing a BRCA2 Gene in a Human Subject
	5/24/2010	Ore Pharmaceuticals, Inc.	Assignee	Application Publication	12402298 20090269814	Method of Analyzing a BRCA2 Gene in a Human Subject Method of Analyzing a BRCA2 Gene in a Human Subject
	9/9/2009	Ocimum Biosolutions, Inc.	Assignee	Application Publication	12043666 20090197258	Primary Rat Hepatocyte Toxicity Modeling Primary Rat Hepatocyte Toxicity Modeling
	7/13/2009	Ocimum Biosolutions, Inc.	Assignee	Application Application Application Application Application Application Publication Patent Patent Patent Patent Patent Patent	09063450 10213881 09158982 10018461 10523499 10212445 20050175228 7251642 7031843 6931396 7020561 6109776 7558411	Methods And Systems For Efficient Comparison, Identification, Processing... Method And System For Managing And Querying Gene Expression Data Accordi... Method And System For Computationally Identifying Clusters Within A Set ... Biological Data Processing Methods And Systems For Efficient Comparison, Identification, Processing... Method And System For Managing And Querying Gene Expression Data Accordi... Computer Methods And Systems For Displaying Information Relating To Gene... Biological Data Processing Analysis Engine And Work Space Manager For Use With Gene Expression Data Method And System For Managing And Querying Gene Expression Data Accordi... Computer Methods And Systems For Displaying Information Relating To Gene... Method And System For Computationally Identifying Clusters Within A Set ... Analysis Engine And Work Space Manager For Use With Gene Expression Data
	1/30/2008	Lg Life Sciences, Ltd.	Assignee	Application Publication	10499698 20060183186	Gene expression profiles in stomach cancer Gene expression profiles in stomach cancer
	1/30/2008	Lg Life Sciences, Ltd.	Assignee	Application Publication	10499695 20080050719	Methods of diagnosing liver cancer Methods of diagnosing liver cancer
	1/18/2008	Ocimum Biosolutions, Inc.	Assignee	Application Application Application Application Application Application Application Application Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Publication Publication Publication Publication Publication Publication Publication ...and 8 more	11790179 10357507 10515373 10501933 10338044 10541937 10152319 10515325 10580423 11059535 11547759 11600759 11036196 11642647 20070054269 20040072160 20070093969 20080281526 20070043515 20110071767 20070061086 20060078900 20070124086 20080264986 20070015147 20070055448 20070027634 ...and 8 more	Methods For Determining Hepatotoxins Molecular Cardiotoxicology Modeling Methods For Determining Hepatotoxins Molecular nephrotoxicology modeling Methods For Determining Renal Toxins Primary rat hepatocyte toxicity modeling Molecular Toxicology Modeling Primary Rat Hepatocyte Toxicity Modeling Modular article carrying system Cardiotoxin molecular toxicology modeling Hepatotoxicity Molecular Models Molecular Cardiotoxicology Modeling Methods For Determining Hepatotoxins Molecular nephrotoxicology modeling Methods For Determining Renal Toxins Methods For Molecular Toxicology Modeling Molecular nephrotoxicology modeling Primary Rat Hepatocyte Toxicity Modeling Molecular Toxicology Modeling Cardiotoxin molecular toxicology modeling Hepatotoxicity Molecular Models Molecular cardiotoxicology modeling Methods For Determining Hepatotoxins Molecular Cardiotoxicology Modeling Methods For Determining Hepatotoxins Methods For Determining Renal Toxins Methods For Molecular Toxicology Modeling ...and 8 more
	1/15/2008	Ore Pharmaceuticals, Inc.	Assignee	Application Application Application Application Publication Publication Publication Patent Patent Patent Patent	10462436 09778468 10727997 11878708 20040147746 20070293498 20040082779 6699873 7365070 7790719 7375125	Modulators Of Melanocortin Receptor Modulators Of Melanocortin Receptor Melanocortin-4 Receptor Binding Compounds And Methods Of Use Thereof Melanocortin-4 Receptor Binding Compounds And Methods Of Use Thereof Modulators Of Melanocortin Receptor Modulators Of Melanocortin Receptor Melanocortin-4 Receptor Binding Compounds And Methods Of Use Thereof Modulators Of Melanocortin Receptor Modulators Of Melanocortin Receptor Melanocortin-4 Receptor Binding Compounds And Methods Of Use Thereof Melanocortin-4 Receptor Binding Compounds And Methods Of Use Thereof
	12/5/2007	Porter, Mark W.	Assignor	Application Publication	11642647 20070124086	Molecular nephrotoxicology modeling Molecular nephrotoxicology modeling
	12/5/2007	Mendrick, Donna L.	Assignor	Application Publication	11642647 20070124086	Molecular nephrotoxicology modeling Molecular nephrotoxicology modeling
	12/5/2007	Johnson, Kory R.	Assignor	Application Publication	11642647 20070124086	Molecular nephrotoxicology modeling Molecular nephrotoxicology modeling
	12/5/2007	Elashoff, Michael	Assignor	Application Publication	11642647 20070124086	Molecular nephrotoxicology modeling Molecular nephrotoxicology modeling
	12/5/2007	Higgs, Brandon	Assignor	Application Publication	11642647 20070124086	Molecular nephrotoxicology modeling Molecular nephrotoxicology modeling
	12/5/2007	Castle, Arthur	Assignor	Application Publication	11642647 20070124086	Molecular nephrotoxicology modeling Molecular nephrotoxicology modeling
	8/23/2007	Elashoff, Michael	Assignor	Application Application Publication Publication	10580423 10580423 20080281526 20080281526	Methods For Molecular Toxicology Modeling Methods For Molecular Toxicology Modeling Methods For Molecular Toxicology Modeling Methods For Molecular Toxicology Modeling
	8/23/2007	Diggans, James	Assignor	Application Application Publication Publication	10580423 10580423 20080281526 20080281526	Methods For Molecular Toxicology Modeling Methods For Molecular Toxicology Modeling Methods For Molecular Toxicology Modeling Methods For Molecular Toxicology Modeling
	8/3/2007	Nadimpalli, Ramgopal	Assignor	Application Publication	10495100 20040234995	System and method for storage and analysis of gene expression data System and method for storage and analysis of gene expression data
	8/3/2007	Huang, Da Wei	Assignor	Application Publication	10495100 20040234995	System and method for storage and analysis of gene expression data System and method for storage and analysis of gene expression data
	8/3/2007	Dolginow, Doug	Assignor	Application Publication	10495100 20040234995	System and method for storage and analysis of gene expression data System and method for storage and analysis of gene expression data
	8/3/2007	Elashoff, Michael	Assignor	Application Publication	10495100 20040234995	System and method for storage and analysis of gene expression data System and method for storage and analysis of gene expression data
	8/3/2007	Diggans, James C.	Assignor	Application Publication	10495100 20040234995	System and method for storage and analysis of gene expression data System and method for storage and analysis of gene expression data
	8/3/2007	Mertz, Larry	Assignor	Application Publication	10495100 20040234995	System and method for storage and analysis of gene expression data System and method for storage and analysis of gene expression data
	8/3/2007	Menezes, Supriya	Assignor	Application Publication	10495100 20040234995	System and method for storage and analysis of gene expression data System and method for storage and analysis of gene expression data
	7/18/2007	Ucb S.a.	Assignor	Application Publication	10491188 20050147969	Genes associated with mast cell activation Genes associated with mast cell activation
	8/31/2006	Porter, Mark	Assignor	Application Publication	10541937 20070054269	Molecular cardiotoxicology modeling Molecular cardiotoxicology modeling
	8/31/2006	Mendrick, Donna	Assignor	Application Publication	10541937 20070054269	Molecular cardiotoxicology modeling Molecular cardiotoxicology modeling
	8/31/2006	Elashoff, Michael	Assignor	Application Publication	10541937 20070054269	Molecular cardiotoxicology modeling Molecular cardiotoxicology modeling
	8/31/2006	Johnson, Kory	Assignor	Application Publication	10541937 20070054269	Molecular cardiotoxicology modeling Molecular cardiotoxicology modeling
	8/31/2006	Higgs, Brandon	Assignor	Application Publication	10541937 20070054269	Molecular cardiotoxicology modeling Molecular cardiotoxicology modeling
	8/31/2006	Castle, Arthur	Assignor	Application Publication	10541937 20070054269	Molecular cardiotoxicology modeling Molecular cardiotoxicology modeling
	6/12/2006	Porter, Mark	Assignor	Application Publication Patent	11036196 20060078900 7426441	Methods For Determining Renal Toxins Methods For Determining Renal Toxins Methods For Determining Renal Toxins
	6/12/2006	Mendrick, Donna	Assignor	Application Publication Patent	11036196 20060078900 7426441	Methods For Determining Renal Toxins Methods For Determining Renal Toxins Methods For Determining Renal Toxins
	6/12/2006	Elashoff, Michael	Assignor	Application Publication Patent	11036196 20060078900 7426441	Methods For Determining Renal Toxins Methods For Determining Renal Toxins Methods For Determining Renal Toxins
	6/12/2006	Johnson, Kory	Assignor	Application Publication Patent	11036196 20060078900 7426441	Methods For Determining Renal Toxins Methods For Determining Renal Toxins Methods For Determining Renal Toxins
	6/12/2006	Higgs, Brandon	Assignor	Application Publication Patent	11036196 20060078900 7426441	Methods For Determining Renal Toxins Methods For Determining Renal Toxins Methods For Determining Renal Toxins
	6/12/2006	Castle, Arthur	Assignor	Application Publication Patent	11036196 20060078900 7426441	Methods For Determining Renal Toxins Methods For Determining Renal Toxins Methods For Determining Renal Toxins
	5/5/2006	Porter, Mark W.	Assignor	Application Publication	10515325 20070093969	Molecular nephrotoxicology modeling Molecular nephrotoxicology modeling
	5/5/2006	Mendrick, Donna L.	Assignor	Application Publication	10515325 20070093969	Molecular nephrotoxicology modeling Molecular nephrotoxicology modeling
	5/5/2006	Johnson, Kory R.	Assignor	Application Publication	10515325 20070093969	Molecular nephrotoxicology modeling Molecular nephrotoxicology modeling
	5/5/2006	Elashoff, Michael	Assignor	Application Publication	10515325 20070093969	Molecular nephrotoxicology modeling Molecular nephrotoxicology modeling
	5/5/2006	Higgs, Brandon	Assignor	Application Publication	10515325 20070093969	Molecular nephrotoxicology modeling Molecular nephrotoxicology modeling
	5/5/2006	Castle, Arthur	Assignor	Application Publication	10515325 20070093969	Molecular nephrotoxicology modeling Molecular nephrotoxicology modeling
	2/15/2006	Porter, Mark	Assignor	Application Publication	10515373 20070055448	Primary rat hepatocyte toxicity modeling Primary rat hepatocyte toxicity modeling
	2/15/2006	Mendrick, Donna	Assignor	Application Publication	10515373 20070055448	Primary rat hepatocyte toxicity modeling Primary rat hepatocyte toxicity modeling
	2/15/2006	Elashoff, Michael	Assignor	Application Publication	10515373 20070055448	Primary rat hepatocyte toxicity modeling Primary rat hepatocyte toxicity modeling
	2/15/2006	Johnson, Kory	Assignor	Application Publication	10515373 20070055448	Primary rat hepatocyte toxicity modeling Primary rat hepatocyte toxicity modeling
	2/15/2006	Higgs, Brandon	Assignor	Application Publication	10515373 20070055448	Primary rat hepatocyte toxicity modeling Primary rat hepatocyte toxicity modeling
	2/15/2006	Castle, Arthur	Assignor	Application Publication	10515373 20070055448	Primary rat hepatocyte toxicity modeling Primary rat hepatocyte toxicity modeling
	2/15/2006	Orr, Michael S.	Assignor	Application Publication	10515373 20070055448	Primary rat hepatocyte toxicity modeling Primary rat hepatocyte toxicity modeling
	1/11/2006	Lg Life Sciences Ltd.	Assignee	Application Publication	10524258 20060121471	Gene families associated with stomach cancer Gene families associated with stomach cancer
	10/20/2005	Lg Life Sciences Ltd.	Assignee	Application Publication	10524530 20060242721	Gene families associated with liver cancer Gene families associated with liver cancer
	6/17/2005	Gene Logic Acquisition Corporation	Assignor	Application Publication Patent	09923327 20030096236 6951721	Method For Determining The Haplotype Of A Human Brca1 Gene Method For Determining The Haplotype Of A Human Brca1 Gene Method For Determining The Haplotype Of A Human Brca1 Gene
	4/18/2005	Wilson, Daniel J.	Assignor	Application Publication	10948635 20050170375	Methods for enhancing gene expression analysis Methods for enhancing gene expression analysis
	4/18/2005	Hoke, Glenn D.	Assignor	Application Publication	10948635 20050170375	Methods for enhancing gene expression analysis Methods for enhancing gene expression analysis
	4/18/2005	Barnes, Debra A.	Assignor	Application Publication	10948635 20050170375	Methods for enhancing gene expression analysis Methods for enhancing gene expression analysis
	4/18/2005	Scherf, Uwe	Assignor	Application Publication	10948635 20050170375	Methods for enhancing gene expression analysis Methods for enhancing gene expression analysis
	4/11/2005	Elashoff, Michael	Assignor	Application Publication Patent	10523499 20050175228 7558411	Method And System For Managing And Querying Gene Expression Data Accordi... Method And System For Managing And Querying Gene Expression Data Accordi... Method And System For Managing And Querying Gene Expression Data Accordi...
	4/11/2005	Alvares, Chris	Assignor	Application Publication Patent	10523499 20050175228 7558411	Method And System For Managing And Querying Gene Expression Data Accordi... Method And System For Managing And Querying Gene Expression Data Accordi... Method And System For Managing And Querying Gene Expression Data Accordi...
	4/11/2005	Lauren, Peter	Assignor	Application Publication Patent	10523499 20050175228 7558411	Method And System For Managing And Querying Gene Expression Data Accordi... Method And System For Managing And Querying Gene Expression Data Accordi... Method And System For Managing And Querying Gene Expression Data Accordi...
	4/11/2005	Wilson, Daniel J.	Assignor	Application Publication	10504072 20050221310	Methods for enhancing gene expression analysis Methods for enhancing gene expression analysis
	4/11/2005	Hoke, Glenn D.	Assignor	Application Publication	10504072 20050221310	Methods for enhancing gene expression analysis Methods for enhancing gene expression analysis
	4/11/2005	Barnes, Debra A.	Assignor	Application Publication	10504072 20050221310	Methods for enhancing gene expression analysis Methods for enhancing gene expression analysis
	4/11/2005	Scherf, Uwe	Assignor	Application Publication	10504072 20050221310	Methods for enhancing gene expression analysis Methods for enhancing gene expression analysis
	3/30/2005	Dolginow, Doug	Assignor	Application Patent	10850232 7428554	System And Method For Determining Matching Patterns Within Gene Expressi... System And Method For Determining Matching Patterns Within Gene Expressi...
	3/30/2005	Elashoff, Michael	Assignor	Application Patent	10850232 7428554	System And Method For Determining Matching Patterns Within Gene Expressi... System And Method For Determining Matching Patterns Within Gene Expressi...
	3/30/2005	Diggans, James C .	Assignor	Application Patent	10850232 7428554	System And Method For Determining Matching Patterns Within Gene Expressi... System And Method For Determining Matching Patterns Within Gene Expressi...
	3/30/2005	Coberly, Carter	Assignor	Application Patent	10850232 7428554	System And Method For Determining Matching Patterns Within Gene Expressi... System And Method For Determining Matching Patterns Within Gene Expressi...
	3/30/2005	Mertz, Larry	Assignor	Application Patent	10850232 7428554	System And Method For Determining Matching Patterns Within Gene Expressi... System And Method For Determining Matching Patterns Within Gene Expressi...
	10/27/2004	Porter, Mark W.	Assignor	Application Publication	10501933 20070027634	Methods For Determining Hepatotoxins Methods For Determining Hepatotoxins
	10/27/2004	Mendrick, Donna L.	Assignor	Application Publication	10501933 20070027634	Methods For Determining Hepatotoxins Methods For Determining Hepatotoxins
	10/27/2004	Johnson, Kory R.	Assignor	Application Publication	10501933 20070027634	Methods For Determining Hepatotoxins Methods For Determining Hepatotoxins
	10/27/2004	Castle, Arthur L.	Assignor	Application Publication	10501933 20070027634	Methods For Determining Hepatotoxins Methods For Determining Hepatotoxins
	10/27/2004	Elashoff, Michael	Assignor	Application Publication	10501933 20070027634	Methods For Determining Hepatotoxins Methods For Determining Hepatotoxins
	10/27/2004	Higgs, Brandon	Assignor	Application Publication	10501933 20070027634	Methods For Determining Hepatotoxins Methods For Determining Hepatotoxins
	9/30/2004	Scherf, Uwe	Assignor	Application Publication	10479866 20050014142	Hybridization normalization methods Hybridization normalization methods
	9/30/2004	Elashoff, Michael	Assignor	Application Publication	10479866 20050014142	Hybridization normalization methods Hybridization normalization methods
	9/30/2004	Beazer-barclay, Yasmin	Assignor	Application Publication	10479866 20050014142	Hybridization normalization methods Hybridization normalization methods
	9/30/2004	Antonellis, Kristen J.	Assignor	Application Publication	10479866 20050014142	Hybridization normalization methods Hybridization normalization methods
	9/30/2004	Mertz, Lawrence	Assignor	Application Publication	10485571 20050037454	Gene associated with bone disorders Gene associated with bone disorders
	8/31/2004	Millennium Pharmaceuticals, Inc.	Assignor	Application Application Application Application Publication Publication Publication Patent Patent Patent	10462436 09778468 10727997 10206893 20040147746 20030053951 20040082779 6699873 7365070 7375125	Melanocortin-4 Receptor Binding Compounds And Methods Of Use Thereof Melanocortin-4 Receptor Binding Compounds And Methods Of Use Thereof Use of non-invasive imaging technologies to monitor in vivo gene-express... Modulators Of Melanocortin Receptor Melanocortin-4 Receptor Binding Compounds And Methods Of Use Thereof Use of non-invasive imaging technologies to monitor in vivo gene-express... Modulators Of Melanocortin Receptor Melanocortin-4 Receptor Binding Compounds And Methods Of Use Thereof Melanocortin-4 Receptor Binding Compounds And Methods Of Use Thereof Modulators Of Melanocortin Receptor
	8/27/2004	Scherrf, Uwe	Assignor	Application Publication	10483889 20050015206	Nucleic acid detection assay control genes Nucleic acid detection assay control genes
	8/24/2004	Einstein, Richard	Assignor	Application Publication	10450826 20040101818	Gene expression profiles associated with osteoblast differentiation Gene expression profiles associated with osteoblast differentiation
	8/24/2004	Mertz, Lawrence	Assignor	Application Publication	10450826 20040101818	Gene expression profiles associated with osteoblast differentiation Gene expression profiles associated with osteoblast differentiation
	7/20/2004	Einstein, Richard	Assignor	Application Publication	10450826 20040101818	Gene expression profiles associated with osteoblast differentiation Gene expression profiles associated with osteoblast differentiation
	7/20/2004	Mertz, Lawrence	Assignor	Application Publication	10450826 20040101818	Gene expression profiles associated with osteoblast differentiation Gene expression profiles associated with osteoblast differentiation
	7/20/2004	Mertz, Lawrence	Assignor	Application Publication	10450859 20040109850	Treatment of bone disorders by modulation of fgfr3 Treatment of bone disorders by modulation of fgfr3
	5/7/2004	Wilson, Daniel J.	Assignor	Application Publication	10479724 20040181049	Rna purification methods Rna purification methods
	5/7/2004	Orr, Michael S.	Assignor	Application Publication	10479724 20040181049	Rna purification methods Rna purification methods
	5/7/2004	Bednarik, Daniel	Assignor	Application Publication	10479724 20040181049	Rna purification methods Rna purification methods
	4/19/2004	Elashoff, Michael	Assignor	Application Publication Patent	10523499 20050175228 7558411	Method And System For Managing And Querying Gene Expression Data Accordi... Method And System For Managing And Querying Gene Expression Data Accordi... Method And System For Managing And Querying Gene Expression Data Accordi...
	4/19/2004	Alvares, Chris	Assignor	Application Publication Patent	10523499 20050175228 7558411	Method And System For Managing And Querying Gene Expression Data Accordi... Method And System For Managing And Querying Gene Expression Data Accordi... Method And System For Managing And Querying Gene Expression Data Accordi...
	4/19/2004	Lauren, Peter	Assignor	Application Publication Patent	10523499 20050175228 7558411	Method And System For Managing And Querying Gene Expression Data Accordi... Method And System For Managing And Querying Gene Expression Data Accordi... Method And System For Managing And Querying Gene Expression Data Accordi...
	3/18/2004	Mertz, Lawrence	Assignor	Application Publication	10471731 20040115686	Materials and methods to detect alternative splicing of mrna Materials and methods to detect alternative splicing of mrna
	3/18/2004	Dolginow, Doulgas	Assignor	Application Publication	10471731 20040115686	Materials and methods to detect alternative splicing of mrna Materials and methods to detect alternative splicing of mrna
	1/21/2004	Japan Tobacco, Inc.	Assignor	Application Publication	09873319 20030134324	Identifying drugs for and diagnosis of Benign Prostatic Hyperplasia usin... Identifying drugs for and diagnosis of Benign Prostatic Hyperplasia usin...
	1/21/2004	Japan Tobacco, Inc.	Assignor	Application Publication Patent	09960706 20030134280 7321830	Identifying Drugs For And Diagnosis Of Benign Prostatic Hyperplasia Usin... Identifying Drugs For And Diagnosis Of Benign Prostatic Hyperplasia Usin... Identifying Drugs For And Diagnosis Of Benign Prostatic Hyperplasia Usin...
	1/16/2004	Japan Tobacco, Inc.	Assignor	Application Publication Patent	09960706 20030134280 7321830	Identifying Drugs For And Diagnosis Of Benign Prostatic Hyperplasia Usin... Identifying Drugs For And Diagnosis Of Benign Prostatic Hyperplasia Usin... Identifying Drugs For And Diagnosis Of Benign Prostatic Hyperplasia Usin...
	1/5/2004	Porter, Mark W.	Assignor	Application Publication	10633306 20040110193	Methods for classification of biological data Methods for classification of biological data
	1/5/2004	Johnson, Kory R.	Assignor	Application Publication	10633306 20040110193	Methods for classification of biological data Methods for classification of biological data
	1/5/2004	Castle, Arthur L.	Assignor	Application Publication	10633306 20040110193	Methods for classification of biological data Methods for classification of biological data
	1/5/2004	Elashoff, Michael R.	Assignor	Application Publication	10633306 20040110193	Methods for classification of biological data Methods for classification of biological data
	12/15/2003	Mertz, Lawrence	Assignor	Application Publication	10450859 20040109850	Treatment of bone disorders by modulation of fgfr3 Treatment of bone disorders by modulation of fgfr3
	9/29/2003	Kulkarni, Prakash	Assignor	Application Publication	09873319 20030134324	Identifying drugs for and diagnosis of Benign Prostatic Hyperplasia usin... Identifying drugs for and diagnosis of Benign Prostatic Hyperplasia usin...
	9/29/2003	Munger, William E.	Assignor	Application Publication	09873319 20030134324	Identifying drugs for and diagnosis of Benign Prostatic Hyperplasia usin... Identifying drugs for and diagnosis of Benign Prostatic Hyperplasia usin...
	9/8/2003	Porter, Mark W.	Assignor	Application Publication Patent	10357507 20070015147 7469185	Primary Rat Hepatocyte Toxicity Modeling Primary Rat Hepatocyte Toxicity Modeling Primary Rat Hepatocyte Toxicity Modeling
	9/8/2003	Orr, Michael	Assignor	Application Publication Patent	10357507 20070015147 7469185	Primary Rat Hepatocyte Toxicity Modeling Primary Rat Hepatocyte Toxicity Modeling Primary Rat Hepatocyte Toxicity Modeling
	9/8/2003	Mendrick, Donna L.	Assignor	Application Publication Patent	10357507 20070015147 7469185	Primary Rat Hepatocyte Toxicity Modeling Primary Rat Hepatocyte Toxicity Modeling Primary Rat Hepatocyte Toxicity Modeling
	9/8/2003	Johnson, Kory R.	Assignor	Application Publication Patent	10357507 20070015147 7469185	Primary Rat Hepatocyte Toxicity Modeling Primary Rat Hepatocyte Toxicity Modeling Primary Rat Hepatocyte Toxicity Modeling
	9/8/2003	Castle, Arthur L.	Assignor	Application Publication Patent	10357507 20070015147 7469185	Primary Rat Hepatocyte Toxicity Modeling Primary Rat Hepatocyte Toxicity Modeling Primary Rat Hepatocyte Toxicity Modeling
	9/8/2003	Elashoff, Michael R.	Assignor	Application Publication Patent	10357507 20070015147 7469185	Primary Rat Hepatocyte Toxicity Modeling Primary Rat Hepatocyte Toxicity Modeling Primary Rat Hepatocyte Toxicity Modeling
	9/8/2003	Higgs, Brandon	Assignor	Application Publication Patent	10357507 20070015147 7469185	Primary Rat Hepatocyte Toxicity Modeling Primary Rat Hepatocyte Toxicity Modeling Primary Rat Hepatocyte Toxicity Modeling
	7/30/2003	Scherf, Uwe	Assignor	Application Publication	10629618 20040048297	Nucleic acid detection assay control genes Nucleic acid detection assay control genes
	7/25/2003	Orr, Michael S.	Assignor	Application Publication	10470050 20070015148	Gene expression profiles in breast tissue Gene expression profiles in breast tissue
	7/25/2003	Nation, Michelle	Assignor	Application Publication	10470050 20070015148	Gene expression profiles in breast tissue Gene expression profiles in breast tissue
	7/25/2003	Diggans, James C.	Assignor	Application Publication	10470050 20070015148	Gene expression profiles in breast tissue Gene expression profiles in breast tissue
	7/25/2003	Zeng, Wen	Assignor	Application Publication	10470050 20070015148	Gene expression profiles in breast tissue Gene expression profiles in breast tissue
	6/12/2003	Vockley, Joseph G.	Assignor	Application Publication	10240425 20040033502	Gene expression profiles in esophageal tissue Gene expression profiles in esophageal tissue
	6/12/2003	Scherf, Uwe	Assignor	Application Publication	10240425 20040033502	Gene expression profiles in esophageal tissue Gene expression profiles in esophageal tissue
	6/12/2003	Williams, Amanda	Assignor	Application Publication	10240425 20040033502	Gene expression profiles in esophageal tissue Gene expression profiles in esophageal tissue
	6/12/2003	Bolan, Joseph F.	Assignor	Application Publication	10240425 20040033502	Gene expression profiles in esophageal tissue Gene expression profiles in esophageal tissue
	6/12/2003	Lord, Reginald V.	Assignor	Application Publication	10240425 20040033502	Gene expression profiles in esophageal tissue Gene expression profiles in esophageal tissue
	6/12/2003	Alvares, Christopher	Assignor	Application Publication	10240425 20040033502	Gene expression profiles in esophageal tissue Gene expression profiles in esophageal tissue
	6/12/2003	Wetzel, Jon C.	Assignor	Application Publication	10240425 20040033502	Gene expression profiles in esophageal tissue Gene expression profiles in esophageal tissue
	6/3/2003	Porter, Mark W.	Assignor	Application Publication Patent	10338044 20070082332 7447594	Molecular Cardiotoxicology Modeling Molecular Cardiotoxicology Modeling Molecular Cardiotoxicology Modeling
	6/3/2003	Mendrick, Donna L.	Assignor	Application Publication Patent	10338044 20070082332 7447594	Molecular Cardiotoxicology Modeling Molecular Cardiotoxicology Modeling Molecular Cardiotoxicology Modeling
	6/3/2003	Johnson, Kory R.	Assignor	Application Publication Patent	10338044 20070082332 7447594	Molecular Cardiotoxicology Modeling Molecular Cardiotoxicology Modeling Molecular Cardiotoxicology Modeling
	6/3/2003	Elashoff, Michael	Assignor	Application Publication Patent	10338044 20070082332 7447594	Molecular Cardiotoxicology Modeling Molecular Cardiotoxicology Modeling Molecular Cardiotoxicology Modeling
	6/3/2003	Higgs, Brandon	Assignor	Application Publication Patent	10338044 20070082332 7447594	Molecular Cardiotoxicology Modeling Molecular Cardiotoxicology Modeling Molecular Cardiotoxicology Modeling
	6/3/2003	Castle, Arthur	Assignor	Application Publication Patent	10338044 20070082332 7447594	Molecular Cardiotoxicology Modeling Molecular Cardiotoxicology Modeling Molecular Cardiotoxicology Modeling
	5/6/2003	Porter, Mark W.	Assignor	Application Publication	10301856 20070015146	Molecular nephrotoxicology modeling Molecular nephrotoxicology modeling
	5/6/2003	Mendrick, Donna L.	Assignor	Application Publication	10301856 20070015146	Molecular nephrotoxicology modeling Molecular nephrotoxicology modeling
	5/6/2003	Johnson, Kory R.	Assignor	Application Publication	10301856 20070015146	Molecular nephrotoxicology modeling Molecular nephrotoxicology modeling
	5/6/2003	Elashoff, Michael	Assignor	Application Publication	10301856 20070015146	Molecular nephrotoxicology modeling Molecular nephrotoxicology modeling
	5/6/2003	Higgs, Brandon	Assignor	Application Publication	10301856 20070015146	Molecular nephrotoxicology modeling Molecular nephrotoxicology modeling
	5/6/2003	Castle, Arthur	Assignor	Application Publication	10301856 20070015146	Molecular nephrotoxicology modeling Molecular nephrotoxicology modeling
	4/4/2003	Gene Logic Acquisition Corporation	Assignor	Application Patent	08984034 6051379	Cancer Susceptibility Mutations Of Brca2 Cancer Susceptibility Mutations Of Brca2
	4/4/2003	Gene Logic Acquisition Corporation	Assignor	Application Patent	08988706 6083698	Cancer Susceptibility Mutations Of Brca1 Cancer Susceptibility Mutations Of Brca1

139 Rows Total

	Date Recorded	Party	Role	Document Type	Document No.	Image
	10/15/2001	Metrigenix Inc.	Assignee	Trademark	2857027
	10/15/2001	Metrigenix Inc.	Assignee	Trademark	2635580
	10/29/2002	B & G Labs, Inc.	Assignee	Trademark	2065746
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Application	76234032
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Application	78451936
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Trademark	2617245
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Application	76213284
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Trademark	2913507
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Application	75647081
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Trademark	2320466
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Application	76213286
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Application	78629365
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Trademark	2923611
	3/28/2008	Ore Pharmaceuticals Inc.	Assignee	Application	77308165
	3/28/2008	Ore Pharmaceuticals Inc.	Assignee	Application	77308643
	10/15/2001	Metrigenix Inc.	Assignee	Application	76263934
	10/15/2001	Metrigenix Inc.	Assignee	Application	75379082
	10/29/2002	B & G Labs, Inc.	Assignee	Application	74713714
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Application	75497305
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Trademark	2900302
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Application	76440016
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Trademark	2928187
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Trademark	3015110
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Application	76316620
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Trademark	2393769
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Application	75497301
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Trademark	2875217
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Trademark	3697108
	3/28/2008	Ore Pharmaceuticals Inc.	Assignee	Trademark	3785232
	3/28/2008	Ore Pharmaceuticals Inc.	Assignee	Trademark	0
	10/15/2001	Metrigenix Inc.	Assignee	Trademark	0
	10/15/2001	Metrigenix Inc.	Assignee	Trademark	2635580
	10/15/2001	Metrigenix Inc.	Assignee	Trademark	2802859
	10/29/2002	B & G Labs, Inc.	Assignee	Trademark	2087300
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Application	76503030
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Trademark	2277741
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Application	75497304
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Trademark	3063740
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Application	76505420
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Application	78398553
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Trademark	3146474
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Application	75081316
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Trademark	2525461
	3/28/2008	Ore Pharmaceuticals Inc.	Assignee	Application	78790033
	3/28/2008	Ore Pharmaceuticals Inc.	Assignee	Application	77308650
	10/15/2001	Metrigenix Inc.	Assignee	Application	75497310
	10/15/2001	Metrigenix Inc.	Assignee	Application	75379082
	10/15/2001	Metrigenix Inc.	Assignee	Application	76205948
	10/29/2002	B & G Labs, Inc.	Assignee	Application	75105087
	3/27/2008	Ocimum Biosolutions, Inc.	Assignee	Application	76213285

60 Rows Total	Page 1 of 2 | Go To

Corporate Family (28)

Track Corporate Family

• Barger Dennis, None
• Blake Jules Phd, None
• Brennan, Michael J., None
• Brinkerhoff Van Wyck, None
• Dimmler Charles L III, None
• Dolginow Y Douglas Md, None
• Donahue, Stephen R., None
• Douglas Frank L, None
• Dunne Chris T, None
• Fordyce James W, None
• Gabrielson, Mark J., None
• Gessler, Mark D., None
• Gibson Terry, None
• Gorry G Anthony Phd, None
• Howard Jack L, None
• Kong Kenneth, None
• Lichtenstein Warren G, None
• Miller, Lloyd I., Iii, None
• Palleiko Benjamin L, None
• Proulx, Robert, None
• Rohrer Philip L Jr, None
• Rossi, Dennis, None
• Smith-Farrell Joanne, None
• Staples F Dudley Jr, None
• Tartaglia, Louis A., None
• Thompson J Stark Phd, None
• Tiffany Larry M, None
• Urdal, David, None

Subsidiaries

• Rossi, Dennis
• Tartaglia, Louis A.
• Gessler, Mark D.
• Gabrielson, Mark J.
• Proulx, Robert
• Miller, Lloyd I., Iii
• Brennan, Michael J.
• Dimmler Charles L III
• Rohrer Philip L Jr
• Staples F Dudley Jr
• Blake Jules Phd
• Dolginow Y Douglas Md
• Gorry G Anthony Phd
• Thompson J Stark Phd
• Smith-Farrell Joanne
• Douglas Frank L
• Barger Dennis
• Brinkerhoff Van Wyck
• Urdal, David
• Tiffany Larry M
• Donahue, Stephen R.
• Palleiko Benjamin L
• Fordyce James W
• Lichtenstein Warren G
• Dunne Chris T
• Kong Kenneth
• Howard Jack L
• Gibson Terry

Sign in to add additional links.

Incoming Payments

This organization has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This organization has not disclosed any outgoing payments to lobbying groups.